Evaluating Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Using Real-World Data
Tumor necrosis factor (TNF) inhibitors were the most frequently used treatment strategy in patients with more severe chronic nonbacterial osteomyelitis, particularly those with spinal involvement or a higher magnetic resonance imaging lesion burden, and achieved the highest remission rate.